InVivoPlus anti-mouse OX40 (CD134)

Catalog number: BP0031_100mg
Brand: Bio X Cell
Packing: 100 mg
Other sizes: 5 mg
25 mg
50 mg
Price: € 3350.00
Expected delivery time: 7 days
Quantity:

Product specifications for - InVivoPlus anti-mouse OX40 (CD134)

Promotion: 
Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Overview: 
Product group: Antibodies
Category: Primary Antibodies
Application: Other Application
Species: Mouse
Host: Rat
Clonality: Monoclonal
Isotype: IgG1 Kappa
Properties: 
Molecular weight: 150 kDa
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 2-10 mg/ml
Scientific information: 
Clone ID: OX-86
Related products: 
Related products: Recommended Isotype Control(s): InVivoPlus rat IgG1 isotype control (anti-HRP) (BP0088), InVivoPlus rat IgG1 isotype control (BP0290)
Recommended Dilution Buffer: InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information: 
Synonyms: OX-86; BP0031; BioXCell
Bartkowiak T, Singh S, Yang G, et al. Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine. Proc Natl Acad Sci USA. 2015;112(38):E5290-9. Read more
Zander RA, Obeng-adjei N, Guthmiller JJ, et al. PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity. Cell Host Microbe. 2015;17(5):628-41. Read more
Makkouk A, Joshi VB, Lemke CD, et al. Three steps to breaking immune tolerance to lymphoma: a microparticle approach. Cancer Immunol Res. 2015;3(4):389-98. Read more
Guo Z, Wang X, Cheng D, Xia Z, Luan M, Zhang S. PD-1 blockade and OX40 triggering synergistically protects against tumor growth in a murine model of ovarian cancer. PLoS ONE. 2014;9(2):e89350. Read more
Krupnick AS, Lin X, Li W, et al. Central memory CD8+ T lymphocytes mediate lung allograft acceptance. J Clin Invest. 2014;124(3):1130-43. Read more
Hu Z, Zhang W, Usherwood EJ. Regulatory CD8+ T cells associated with erosion of immune surveillance in persistent virus infection suppress in vitro and have a reversible proliferative defect. J Immunol. 2013;191(1):312-22. Read more
Kurche JS, Haluszczak C, Mcwilliams JA, Sanchez PJ, Kedl RM. Type I IFN-dependent T cell activation is mediated by IFN-dependent dendritic cell OX40 ligand expression and is independent of T cell IFNR expression. J Immunol. 2012;188(2):585-93. Read more
Xiao X, Gong W, Demirci G, et al. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J Immunol. 2012;188(2):892-901. Read more
Murray SE, Polesso F, Rowe AM, et al. NF-κB–inducing kinase plays an essential T cell–intrinsic role in graft-versus-host disease and lethal autoimmunity in mice. J Clin Invest. 2011;121(12):4775-86. Read more